InnerPlant takes ‘meaningful step’ in regulatory journey

InnerPlant has successfully completed the FDA’s New Protein Consultation for its InnerSoy product, which utilizes fluorescent proteins to signal plant distress. This regulatory milestone is crucial for advancing the commercialization of genetically engineered sensor plants, potentially enhancing agricultural efficiency and pest management. The company aims to expand its CropVoice fungal alert network in key U.S. states, further solidifying its market presence.

Original excerpt: InnerPlant has completed the FDA’s New Protein Consultation (NPC) process for the fluorescent protein used in its InnerSoy product…

Source: AgFunderNews